Literature DB >> 12739762

Induction of cytochrome P450 2B6 and 3A4 expression by phenobarbital and cyclophosphamide in cultured human liver slices.

Hélène Martin1, Jean-Pierre Sarsat, Isabelle de Waziers, Chantal Housset, Pierre Balladur, Philippe Beaune, Véronique Albaladejo, Carole Lerche-Langrand.   

Abstract

PURPOSE: To examine the potential of cultured human liver slices to predict cytochrome P450 (CYP) inducibility, regarding global and zonal CYP expression, together with drug-induced histologic changes.
METHODS: We first assessed whether CYP2B6, 3A4, and 2C9 expression was maintained in cultured liver slices. Cultured hepatocytes were used as the reference culture system. Then we tested the effects of phenobarbital and cyclophosphamide on CYP expression in both models.
RESULTS: Morphologic features are preserved in slices. Basal CYP expression declines with time in culture in both models. Slices display the same region specificity of CYP2B6, 2C9, and 3A4 expression as intact liver. CYP2B6 and 3A4 mRNA, apoprotein, and enzyme-related activities were induced by phenobarbital and cyclophosphamide, whereas CYP2C9 apoprotein was not. Their immunoreactivities were also increased, while their zonal distribution was preserved on slice tissue sections. Microsomal enzyme induction was confirmed by histology.
CONCLUSIONS: Cultured human liver slices are an attractive alternative to hepatocyte culture for the prediction of human CYP isoenzyme induction by xenobiotics.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739762     DOI: 10.1023/a:1023234429596

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  29 in total

1.  Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.

Authors:  H Yamazaki; T Shimada
Journal:  Arch Biochem Biophys       Date:  1997-10-01       Impact factor: 4.013

Review 2.  Use of precision-cut liver slices as an in vitro tool for evaluating liver function.

Authors:  A J Gandolfi; J Wijeweera; K Brendel
Journal:  Toxicol Pathol       Date:  1996 Jan-Feb       Impact factor: 1.902

3.  Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes.

Authors:  N Milosevic; H Schawalder; P Maier
Journal:  Eur J Pharmacol       Date:  1999-02-26       Impact factor: 4.432

Review 4.  Immunohistochemistry of drug-metabolizing enzymes.

Authors:  G I Murray; M D Burke
Journal:  Biochem Pharmacol       Date:  1995-09-28       Impact factor: 5.858

5.  Induction of CYP3A isoforms in cultured precision-cut human liver slices.

Authors:  B G Lake; S E Ball; A B Renwick; J M Tredger; J Kao; J A Beamand; R J Price
Journal:  Xenobiotica       Date:  1997-11       Impact factor: 1.908

6.  Monospecific antipeptide antibody to cytochrome P-450 2B6.

Authors:  D M Stresser; D Kupfer
Journal:  Drug Metab Dispos       Date:  1999-04       Impact factor: 3.922

7.  Human CYP2B6: expression, inducibility and catalytic activities.

Authors:  L Gervot; B Rochat; J C Gautier; F Bohnenstengel; H Kroemer; V de Berardinis; H Martin; P Beaune; I de Waziers
Journal:  Pharmacogenetics       Date:  1999-06

8.  Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes.

Authors:  E G Schuetz; J D Schuetz; S C Strom; M T Thompson; R A Fisher; D T Molowa; D Li; P S Guzelian
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

9.  Alterations of the catalytic activities of drug-metabolizing enzymes in cultures of human liver slices.

Authors:  M VandenBranden; S A Wrighton; S Ekins; J S Gillespie; S N Binkley; B J Ring; M G Gadberry; D C Mullins; S C Strom; C B Jensen
Journal:  Drug Metab Dispos       Date:  1998-11       Impact factor: 3.922

10.  3,3'-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices.

Authors:  B G Lake; J M Tredger; A B Renwick; P T Barton; R J Price
Journal:  Xenobiotica       Date:  1998-08       Impact factor: 1.908

View more
  14 in total

1.  A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas.

Authors:  Shivaani Kummar; Jiuping Ji; Robert Morgan; Heinz-Josef Lenz; Shannon L Puhalla; Chandra P Belani; David R Gandara; Deborah Allen; Brian Kiesel; Jan H Beumer; Edward M Newman; Larry Rubinstein; Alice Chen; Yiping Zhang; Lihua Wang; Robert J Kinders; Ralph E Parchment; Joseph E Tomaszewski; James H Doroshow
Journal:  Clin Cancer Res       Date:  2012-02-03       Impact factor: 12.531

2.  Evaluation of human liver slices and reporter gene assays as systems for predicting the cytochrome p450 induction potential of drugs in vivo in humans.

Authors:  Kajsa P Persson; Susanne Ekehed; Charlotta Otter; E S Mareike Lutz; Jane McPheat; Collen M Masimirembwa; Tommy B Andersson
Journal:  Pharm Res       Date:  2006-11-22       Impact factor: 4.200

Review 3.  Interactions between antiepileptic and antipsychotic drugs.

Authors:  Frank M C Besag; David Berry
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

5.  Integrated Population Pharmacokinetic Model of both cyclophosphamide and thiotepa suggesting a mutual drug-drug interaction.

Authors:  Milly E de Jonge; Alwin D R Huitema; Sjoerd Rodenhuis; Jos H Beijnen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-04       Impact factor: 2.745

Review 6.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  Milly E de Jonge; Alwin D R Huitema; Sjoerd Rodenhuis; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

7.  A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer.

Authors:  R K Kelley; J Hwang; M J M Magbanua; L Watt; J H Beumer; S M Christner; S Baruchel; B Wu; L Fong; B M Yeh; A P Moore; A H Ko; W M Korn; S Rajpal; J W Park; M A Tempero; A P Venook; E K Bergsland
Journal:  Br J Cancer       Date:  2013-09-10       Impact factor: 7.640

8.  An in vitro model of human acute ethanol exposure that incorporates CXCR3- and CXCR4-dependent recruitment of immune cells.

Authors:  Sumera Karim; Evaggelia Liaskou; Samuel Hadley; Janine Youster; Jeff Faint; David H Adams; Patricia F Lalor
Journal:  Toxicol Sci       Date:  2013-01-08       Impact factor: 4.849

9.  Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.

Authors:  Nuala Helsby; Minghan Yong; Kathryn Burns; Michael Findlay; David Porter
Journal:  Cancer Chemother Pharmacol       Date:  2021-06-10       Impact factor: 3.333

Review 10.  The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism.

Authors:  Hueng-Chuen Fan; Herng-Shen Lee; Kai-Ping Chang; Yi-Yen Lee; Hsin-Chuan Lai; Pi-Lien Hung; Hsiu-Fen Lee; Ching-Shiang Chi
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.